Insulin initiation & titration (type 2 diabetes)
insulin · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Structured starting and dose adjustment of insulin in type 2 diabetes when oral and injectable non-insulin agents no longer achieve targets. Usually begins with basal insulin, advancing to intensified regimens as needed.
Red flags
- Recurrent or severe hypoglycaemia
- Rapid unexplained weight loss or ketosis (consider type 1/LADA)
- Hypoglycaemia unawareness in a driver
- Very high insulin requirements without effect (adherence/intercurrent illness)
Assessment
Differential diagnosis
- Suboptimal adherence to existing therapy
- Steroid-induced hyperglycaemia
- Latent autoimmune diabetes of adults (LADA)
- Pancreatic diabetes
- Undiagnosed infection/stress hyperglycaemia
Investigations
- HbA1c and self-monitored glucose profiles
- Renal function and weight/BMI
- Consider C-peptide and GAD antibodies if LADA suspected
- Review of current regimen and adherence
- Assessment of hypoglycaemia awareness and driving status
Management
- Confirm failure of optimised non-insulin therapy and agree individualised HbA1c target
- Continue metformin and (where possible) GLP-1 agonist/SGLT2 inhibitor
- Stop or reduce sulfonylureas as insulin starts to limit hypoglycaemia
- Start basal insulin ~10 units or 0.1-0.2 units/kg at a consistent time
- Teach injection technique, glucose monitoring and hypoglycaemia management
- Titrate basal dose by 2-4 units every few days to fasting target ~5-7 mmol/L
- If fasting at target but HbA1c high, add prandial insulin or switch to premixed/basal-bolus
- Assess driving (DVLA rules), weight gain and hypoglycaemia at each review
- Reassess whether insulin remains necessary if lifestyle/weight improve
Drugs & doses
Insulin glargine U100/U300 or degludec 10 units SC nocte, titrated
Insulin isophane (NPH) once-twice daily as cheaper basal option
Insulin aspart/lispro with meals for prandial cover
Premixed insulin (e.g. 30/70) twice daily as an alternative regimen
Disposition
Initiate and titrate in primary care/diabetes clinic with structured education; refer to specialist team for suspected type 1/LADA or persistent instability.
Complications & pitfalls
- Hypoglycaemia
- Weight gain
- Injection-site lipohypertrophy
- Over-basalisation (rising dose without benefit)
- Loss of driving licence if poorly controlled
Exam pearls
- Keep metformin and SGLT2/GLP-1 agents going to limit insulin dose and weight gain
- Over-basalisation (basal >0.5 units/kg with high post-meal glucose) needs prandial cover, not more basal
- Degludec and glargine U300 have flatter profiles and less nocturnal hypoglycaemia
- Review driving and occupational implications before starting insulin
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.